Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy.
Mangino
J E
JE
Fass
R J
RJ
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000163:Acquired Immunodeficiency Syndrome / Q000151:congenital / Q000188:drug therapy* / Q000635:transmission; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D015658:HIV Infections / Q000151:congenital / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D010919:Placebos; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D037841:Pregnant People; D012306:Risk; D018570:Risk Assessment; D012307:Risk Factors; D036302:Therapeutic Human Experimentation; D016387:Women's Health; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D010919:Placebos; D015215:Zidovudine